284 related articles for article (PubMed ID: 30054622)
1. Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Moody L; Chan DL; Metz DC; Strosberg J; Asmis T; Bailey DL; Bergsland E; Brendtro K; Carroll R; Cleary S; Kim M; Kong G; Law C; Lawrence B; McEwan A; McGregor C; Michael M; Pasieka J; Pavlakis N; Pommier R; Soulen M; Wyld D; Segelov E;
JAMA Oncol; 2018 Nov; 4(11):1597-1604. PubMed ID: 30054622
[TBL] [Abstract][Full Text] [Related]
2. Aggressive gastro-entero-pancreatic neoplasms.
Coriat R
Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
[No Abstract] [Full Text] [Related]
3. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].
Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM
Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723
[TBL] [Abstract][Full Text] [Related]
4. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Chan DL; Moody L; Liu N; Fischer HD; Austin PC; Segelov E
JAMA Oncol; 2018 Apr; 4(4):583-585. PubMed ID: 29543939
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
Perez K; Chan J
Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
[TBL] [Abstract][Full Text] [Related]
6. Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).
Chan DL; Moody L; Segelov E; Metz DC; Strosberg JR; Pavlakis N; Singh S
Neuroendocrinology; 2018; 107(1):32-41. PubMed ID: 29539613
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
Garcia-Carbonero R
Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
[No Abstract] [Full Text] [Related]
8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
[No Abstract] [Full Text] [Related]
9. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
Van Hootegem P; Borbath I; Verslype C
Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
[No Abstract] [Full Text] [Related]
10. [Surgical treatments for gastroenteropancreatic neuroendocrine tumor (GEP-NET)].
Aoki T; Kokudo N
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2272-9. PubMed ID: 25482902
[No Abstract] [Full Text] [Related]
11. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of neuroendocrine tumors.
Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
[TBL] [Abstract][Full Text] [Related]
13. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
[TBL] [Abstract][Full Text] [Related]
15. Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors.
Watanabe A; Yip L; Hamilton TD; Loree JM; Stuart HC
Am J Surg; 2021 Jun; 221(6):1141-1149. PubMed ID: 33795127
[TBL] [Abstract][Full Text] [Related]
16. [Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy].
Ye C; Yuan CH; Li G; Zheng L; Xiu DR
Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):866-871. PubMed ID: 31694137
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
Sauvanet A
Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
[TBL] [Abstract][Full Text] [Related]
18. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)].
Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
20. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Raj N; Fazio N; Strosberg J
Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
